Clinical treatment of bladder cancer: An addition to Affibody-mediated tumor targeting
Reference number | |
Coordinator | Haldex Holding AB - Haldex Holding AB |
Funding from Vinnova | SEK 542 000 |
Project duration | September 2006 - December 2007 |
Status | Completed |